Pre-order Enquiry
Request Free Sample
Global COVID-19 Rapid Diagnostic Test Kit Market Research Report 2022
SKU ID : QYR-20585396 | Publishing Date : 22-Mar-2022 | No. of pages : 114
Request Sample
Request Customization
Check Discounts
The COVID-19 Rapid Diagnostic Test Kit is divided into COVID-19 Rapid Diagnostic Test Kit and COVID-19 Antigen Rapid Test Kit according to the detection components.
Due to the COVID-19 pandemic, the global COVID-19 Rapid Diagnostic Test Kit market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe COVID-19 Rapid Diagnostic Test Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe COVID-19 Rapid Diagnostic Test Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Antibody Rapid Test Kit accounting for % of the COVID-19 Rapid Diagnostic Test Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of COVID-19 Rapid Diagnostic Test Kit include RayBiotech Life, Aurora Biomed, SD Biosensor, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda, Roche Diagnostics and JOYSBIO, etc. In terms of revenue, the global 3 largest players have a % market share of COVID-19 Rapid Diagnostic Test Kit in 2021.
This report focuses on COVID-19 Rapid Diagnostic Test Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall COVID-19 Rapid Diagnostic Test Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global COVID-19 Rapid Diagnostic Test Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Antibody Rapid Test Kit
Antigen Rapid Test Kit
Segment by Application
Hospital
Company
School
Home
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
RayBiotech Life
Aurora Biomed
SD Biosensor
INSTI
CTK Biotech
SBL Testing Technologies
Biopanda
Roche Diagnostics
JOYSBIO
Abingdon Health
TestLine Clinical Diagnostics
Assay Genie
Nadal-test
Panodyne
Luminex
Abbott
AESKU.GROUP
ARISTA® Biotech
iHealth
Quidel
ACCESS BIO
AUISET
Biotest Biotech
Hangzhou AllTest Biotech
ACON Biotech
Lepu Medical Technology
BGI
Phase Scientific
Assure Tech
BIOHIT Healthcare (Hefei)
Artron Laboratories
Philosys
Innovation Scientific
GenBody Inc
Medriva
Due to the COVID-19 pandemic, the global COVID-19 Rapid Diagnostic Test Kit market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe COVID-19 Rapid Diagnostic Test Kit market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe COVID-19 Rapid Diagnostic Test Kit landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
Antibody Rapid Test Kit accounting for % of the COVID-19 Rapid Diagnostic Test Kit global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of COVID-19 Rapid Diagnostic Test Kit include RayBiotech Life, Aurora Biomed, SD Biosensor, INSTI, CTK Biotech, SBL Testing Technologies, Biopanda, Roche Diagnostics and JOYSBIO, etc. In terms of revenue, the global 3 largest players have a % market share of COVID-19 Rapid Diagnostic Test Kit in 2021.
This report focuses on COVID-19 Rapid Diagnostic Test Kit volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall COVID-19 Rapid Diagnostic Test Kit market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global COVID-19 Rapid Diagnostic Test Kit Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Antibody Rapid Test Kit
Antigen Rapid Test Kit
Segment by Application
Hospital
Company
School
Home
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
RayBiotech Life
Aurora Biomed
SD Biosensor
INSTI
CTK Biotech
SBL Testing Technologies
Biopanda
Roche Diagnostics
JOYSBIO
Abingdon Health
TestLine Clinical Diagnostics
Assay Genie
Nadal-test
Panodyne
Luminex
Abbott
AESKU.GROUP
ARISTA® Biotech
iHealth
Quidel
ACCESS BIO
AUISET
Biotest Biotech
Hangzhou AllTest Biotech
ACON Biotech
Lepu Medical Technology
BGI
Phase Scientific
Assure Tech
BIOHIT Healthcare (Hefei)
Artron Laboratories
Philosys
Innovation Scientific
GenBody Inc
Medriva
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
